John W. Ebert - 12 Dec 2025 Form 4 Insider Report for MVB FINANCIAL CORP (MVBF)

Reporting owner
Signature
Lisa J. McCormick, POA for John W. Ebert
Issuer context
Transaction snapshot
SEC evidence
Form type
4
Filing time
16 Dec 2025, 13:06:26 UTC
Previous filing
03 Jun 2025
SEC filing
View on sec.gov

Key filing fact

John W. Ebert filed Form 4 for MVB FINANCIAL CORP (MVBF) on 16 Dec 2025.

Key facts

  • This page summarizes John W. Ebert's Form 4 filing for MVB FINANCIAL CORP (MVBF).
  • 2 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 16 Dec 2025, 13:06.

Change

  • Previous filing in this sequence was filed on 03 Jun 2025.
  • Current net transaction value: +$12,500.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

CIK 0001343277 Primary reporting owner

Ebert John W

Relationship
Director
Address
164 MEADOWFIELD DR., BRIDGEPORT
Signature
Lisa J. McCormick, POA for John W. Ebert
Signature date
16 Dec 2025

Reported transactions

MVBF transaction

Common Stock

Options Exercise

Transaction value
$12,500
Shares
+1,000
Change %
+0.85%
Price
$12.50
Shares after
118,862
Date
12 Dec 2025
Ownership
Direct
Footnotes
F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

MVBF transaction Derivative

Common Stock Options

Options Exercise

Transaction value
$0
Shares
-1,000
Change %
-100%
Price
$0.000000
Shares after
0
Date
12 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,000
Exercise price
$12.50
Footnotes
F2
* indicates a reported price that failed the local validity check.

Explanation of Responses:

Id Content
F1 Includes 2,428 shares acquired through MVB's Dividend Reinvestment Plan since the last report.
F2 Stock Options granted - 1/5 of the shares became exercisable 02/03/17, 02/03/18, 02/03/19, 02/03/20 and 02/03/21, respectively
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .